Detalles de la búsqueda
1.
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT.
Blood
; 143(24): 2534-2543, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657278
2.
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.
Cancer
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581695
3.
PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Haematologica
; 2024 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38867585
4.
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Br J Haematol
; 201(6): 1169-1178, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949658
5.
Salvage haploidentical or cord-blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM-TC.
Eur J Haematol
; 110(1): 40-49, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151965
6.
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Eur J Haematol
; 111(2): 181-190, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37082839
7.
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Acta Haematol
; 146(3): 230-239, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603565
8.
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study.
Ann Hematol
; 100(5): 1149-1158, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569703
9.
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.
Eur J Haematol
; 107(1): 111-121, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33765335
10.
Risk factors of BK viral hemorrhagic cystitis in allogenic hematopoietic stem cell transplantation.
Transpl Infect Dis
; 23(5): e13601, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724650
11.
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(9): 1798-1802, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31129355
12.
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation.
Haematologica
; 108(2): 645-652, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546480
13.
HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation.
Am J Hematol
; 2018 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29726580
14.
Dynamics of Epstein-Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy.
Transpl Infect Dis
; 18(6): 889-895, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27696681
15.
Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Biol Blood Marrow Transplant
; 21(8): 1452-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25911579
16.
Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
Biol Blood Marrow Transplant
; 21(3): 445-53, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25460357
17.
Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels.
Antimicrob Agents Chemother
; 59(4): 2305-14, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645831
18.
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.
Blood
; 121(12): 2213-23, 2013 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23321257
19.
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica
; 100(5): 683-9, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25769546
20.
Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
Eur J Haematol
; 94(5): 449-55, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25238651